0001640334-22-002377.txt : 20221110
0001640334-22-002377.hdr.sgml : 20221110
20221110061107
ACCESSION NUMBER: 0001640334-22-002377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221109
FILED AS OF DATE: 20221110
DATE AS OF CHANGE: 20221110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu Lina
CENTRAL INDEX KEY: 0001828515
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21320
FILM NUMBER: 221374729
MAIL ADDRESS:
STREET 1: MAGNA-LAB, INC.
STREET 2: ROOM 105, BUILDING 5, 31 XISHIKU AVENUE
CITY: XICHENG DISTRICT, BEIJING
STATE: F4
ZIP: 00000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Yubo International Biotech Ltd
CENTRAL INDEX KEY: 0000895464
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 113074326
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ROOM 105, BUILDING 5, 31 XISHIKU AVENUE
CITY: BEIJING
STATE: F4
ZIP: 00000
BUSINESS PHONE: 86 (010) 6615-5141
MAIL ADDRESS:
STREET 1: ROOM 105, BUILDING 5, 31 XISHIKU AVENUE
CITY: BEIJING
STATE: F4
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: MAGNA LAB INC
DATE OF NAME CHANGE: 19940722
4
1
form4.xml
FORM 4
X0306
4
2022-11-09-05:00
false
0000895464
Yubo International Biotech Ltd
YBGJ
0001828515
Liu Lina
ROOM 105, BUILDING 5, XISHIKU AVENUE
XICHENG DISTRICT
BEIJING
F4
00000
CHINA
false
true
false
false
Chief Financial Officer
Class A Common Stock
2022-11-09-05:00
4
S
false
4728000
0.50
D
9101400
I
By Focus Draw Group Limited
The shares of Class A Common Stock are held directly by Focus Draw Group Limited. Ms. Lina Liu is the sole Director of Focus Draw Group Limited, and as such, Ms. Lina Liu may be deemed to have voting and investment power over such shares held by Focus Draw Group Limited. Ms. Lina Liu disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), except to the extent of her indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
/s/ Lina Liu
2022-11-10-05:00